Company Filing History:
Years Active: 2011-2013
Title: Innovations of William Netzer in Amyloid-β Peptide-Related Disorders
Introduction
William Netzer is a prominent inventor based in New York, NY, known for his significant contributions to the field of biomedical research. He holds two patents that focus on the prevention and treatment of amyloid-β peptide-related disorders, particularly in relation to Alzheimer's disease. His work has the potential to impact the lives of many individuals affected by these conditions.
Latest Patents
Netzer's latest patents include compositions and methods for modulating levels of amyloid-β peptide (Aβ) exhibited by cells or tissues. The inventions provide pharmaceutical compositions and methods for screening compounds that modulate Aβ levels. They also detail methods for preventing, treating, or ameliorating symptoms of disorders related to Aβ by administering modulators of γ-secretase, including selective inhibitors of ATP-dependent γ-secretase activity. These innovations aim to offer new avenues for the treatment of Alzheimer's disease.
Career Highlights
Throughout his career, William Netzer has worked with esteemed institutions such as The Rockefeller University and Intra-cellular Therapies, Inc. His research has garnered attention for its potential to advance therapeutic strategies in neurodegenerative diseases.
Collaborations
Netzer has collaborated with notable scientists, including Paul Greengard and Huaxi Xu, contributing to a rich exchange of ideas and research advancements in his field.
Conclusion
William Netzer's innovative work in the modulation of amyloid-β peptide levels represents a significant step forward in the fight against Alzheimer's disease. His patents and collaborations highlight the importance of continued research in this critical area of health.